Medtronic has announced its schedule for presentations at the 25th North American Neuromodulation Society (NANS) annual meeting (13–15 January 2022; Orlando, USA). According to a press release, Medtronic therapies and technologies will be represented as part of 23 podium and poster presentations.
The company will welcome guests to booth #404 featuring an innovation suite and opportunities to learn from Medtronic scientists and engineers about the new Vanta recharge-free neurostimulator, as well as a new modified energy variation of Differential Target Multiplexed spinal cord stimulation (DTM SCS) known as DTM SCS endurance therapy.
Medtronic will also showcase its targeted drug delivery options for patients with chronic pain, while other Medtronic presentations set to feature at the event cover topics including evoked compound action potentials (ECAPs)—which are used in optimisation of SCS therapy—and deep brain stimulation (DBS) for Parkinson’s disease.
A full list of Medtronic-sponsored scientific presentations at NANS 2022 can be seen here.
